Boston Scientific Corporation
Boston Scientific
Back to Directory   


 
  Recent News
TITLE DATE
Boston Scientific Receives FDA Approval for New Infinion(TM) 16 Percutaneous Lead for Precision Plus(TM) Spinal Cord Stimulator System 8-Dec-2011
Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System 8-Dec-2011
Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties 30-Nov-2011
Boston Scientific Announces FDA Approval and First Implant for New Devices to Treat Heart Failure and Sudden Cardiac Death 30-Nov-2011
Boston Scientific Receives FDA Approval for PROMUS Element(TM) Plus Platinum Chromium Stent System 22-Nov-2011
Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference 18-Nov-2011
Boston Scientific's WATCHMAN(R) Device Implanted in First Patients in Latin America 16-Nov-2011
Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America 16-Nov-2011
Boston Scientific Applauds Introduction of Patient Access to Medical Innovation Act 15-Nov-2011
CryoPlasty(R) Therapy With Boston Scientific PolarCath(TM) Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures 11-Nov-2011
CryoPlasty® Therapy With Boston Scientific PolarCath(TM) Dilatation System Reduces Restenosis Rates by Nearly 50 Percent in Peripheral Stenting Procedures 11-Nov-2011
Boston Scientific SYNERGY(TM) Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element(TM) Platinum Chromium Stent 11-Nov-2011
Boston Scientific CRE(TM) Wireguided Balloon Dilator CE Marked for Expanded Indication 9-Nov-2011
Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice 8-Nov-2011
Boston Scientific's PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 8-Nov-2011
Boston Scientific Platinum Chromium ION(TM) Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program 8-Nov-2011
Boston Scientific SpyGlass® Direct Visualization System Demonstrates High Procedural Success Rate in Published Study 2-Nov-2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium 1-Nov-2011
Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments 27-Oct-2011
Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 20-Oct-2011
Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent 18-Oct-2011
Boston Scientific Launches Promus Element(TM) Stent System In China 17-Oct-2011
Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate 14-Oct-2011
Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 11-Oct-2011
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System 5-Oct-2011
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial 29-Sep-2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent 28-Sep-2011
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM]Bronchial Thermoplasty System 27-Sep-2011
Boston Scientific Launches Coyote(TM) Balloon Catheter 19-Sep-2011
Boston Scientific Sponsors New Patient Portal Dedicated to Pelvic Floor Disorders 15-Sep-2011
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan 13-Sep-2011
Boston Scientific Issues Statement Regarding FDA Advisory Committee Meeting on Surgical Mesh to Treat Pelvic Organ Prolapse and Stress Urinary Incontinence 9-Sep-2011
Boston Scientific to Participate in 2011 Morgan Stanley Global Healthcare Conference 2-Sep-2011
Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation 10-Aug-2011
Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 8-Aug-2011
Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 28-Jul-2011
Boston Scientific Announces $1.0B Share Repurchase Program 28-Jul-2011
Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion 27-Jul-2011
Boston Scientific's Credit Rating Raised to Investment Grade 21-Jul-2011
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2011 Financial Results 14-Jul-2011
Boston Scientific Completes Clinical Trial Enrollment for Adapt(TM) Monorail(TM) Carotid Stent System 12-Jul-2011
Boston Scientific Welcomes Publication of Landmark Report on Chronic Pain 30-Jun-2011
Boston Scientific Announces U.S. and European Launch of Interlock(TM) - 35 Fibered IDC(TM) Occlusion System 30-Jun-2011
Boston Scientific Welcomes Passage of Patent Reform Bill 27-Jun-2011
Boston Scientific Announces Global Launch of Mustang(TM) PTA Balloon Catheter 20-Jun-2011
Boston Scientific to Participate in 2011 Wells Fargo Securities Healthcare Conference 16-Jun-2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents 7-Jun-2011
Boston Scientific Announces Voluntary Recall of iCross(TM) Coronary Imaging Catheters 27-May-2011
Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System 25-May-2011
PROMUS Element(TM) Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study 20-May-2011
Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device 18-May-2011
Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in Treating Severe Asthma 16-May-2011
Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation 11-May-2011
Boston Scientific Announces Retirement of Ray Elliott as President and CEO Effective End of 2011 10-May-2011
Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 10-May-2011
Boston Scientific Begins U.S. and International Launch of Expect(TM) Endoscopic Ultrasound Aspiration Needle 9-May-2011
Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death 6-May-2011
ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 5-May-2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation 5-May-2011
Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones 4-May-2011
Boston Scientific Announces CE Mark Approval and First Use of Blazer(TM) Open-Irrigated Catheter in Europe 3-May-2011
Boston Scientific Announces Its Schedule for Heart Rhythm Society Scientific Sessions 2-May-2011
Boston Scientific to Participate in Bank of America Merrill Lynch 2011 Health Care Conference 27-Apr-2011
Boston Scientific To Participate in Deutsche Bank 36th Annual Health Care Conference 26-Apr-2011
Boston Scientific Announces FDA Approval and U.S. Launch of ION(TM) Platinum Chromium Stent System 25-Apr-2011
Boston Scientific Announces Results for First Quarter Ended March 31, 2011 20-Apr-2011
Boston Scientific to Webcast Conference Call Discussing First Quarter 2011 Financial Results 14-Apr-2011
Boston Scientific Begins International Clinical Trial Enrollment for INNOVA(TM) Self-Expanding Bare-Metal Stent System 5-Apr-2011
Boston Scientific's Promus Element(TM) Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial 4-Apr-2011
Boston Scientific ION(TM) Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data 3-Apr-2011
Boston Scientific Announces Its ACC 2011 Schedule 29-Mar-2011
Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System 24-Mar-2011
Boston Scientific to Webcast Analyst Event 22-Mar-2011
Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference 8-Mar-2011
Boston Scientific Announces European Approval and Launch of OMEGA(TM) Platinum Chromium Stent System 7-Mar-2011
Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech 3-Mar-2011
Boston Scientific Launches PROMUS(R) Element(TM) and TAXUS(R) Element(TM) Stent Systems in India 17-Feb-2011
Boston Scientific to Participate in 2011 RBC Capital Markets' Healthcare Conference 16-Feb-2011
Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions 15-Feb-2011
Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine 15-Feb-2011
Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds 8-Feb-2011
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010 1-Feb-2011
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO(TM) Fathom(R) Pre-Loaded System 31-Jan-2011
Boston Scientific Responds to DOJ Civil Lawsuit 28-Jan-2011
Boston Scientific Announces First Use of Blazer(R) Open-Irrigated Catheter in U.S. 27-Jan-2011
Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element(TM) Everolimus-Eluting Stent 26-Jan-2011
Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY(TM) Drug-Eluting Coronary Stent 24-Jan-2011
Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan 19-Jan-2011
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results 19-Jan-2011
Boston Scientific to Acquire Atritech 19-Jan-2011
Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease 10-Jan-2011
Boston Scientific Acquires Intelect Medical 5-Jan-2011
Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article 4-Jan-2011
Boston Scientific Completes Acquisition of Sadra Medical 4-Jan-2011
Boston Scientific Completes Sale of Neurovascular Business 3-Jan-2011
Boston Scientific to Present at 29th Annual J.P. Morgan Healthcare Conference 27-Dec-2010
Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors 20-Dec-2010
Boston Scientific Welcomes Publication of Analysis of Patients Monitored by the LATITUDE(R) Patient Management System 7-Dec-2010
Boston Scientific to Help Raise Awareness of Heart Disease Risk Factors at College Basketball Showcase Event 6-Dec-2010
Boston Scientific to Participate in Piper Jaffray Health Care Conference 22-Nov-2010
Boston Scientific to Acquire Sadra Medical 19-Nov-2010
Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death 19-Nov-2010
Alair(R) Bronchial Thermoplasty System Named 'Best of What's New' By Popular Science 17-Nov-2010
Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2010 11-Nov-2010
Boston Scientific To Webcast Investor Day Meeting 10-Nov-2010
Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease 9-Nov-2010
Bronchial Thermoplasty Demonstrates Long-Term Asthma Control in Patients With Severe Asthma 2-Nov-2010
Boston Scientific Agrees to Sell Neurovascular Business to Stryker 28-Oct-2010
Boston Scientific Completes Acquisition of Asthmatx 26-Oct-2010
Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex(R) Biliary RX Stent 22-Oct-2010
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix(TM) Biliary Stents 21-Oct-2010
Boston Scientific Announces Results for Third Quarter Ended September 30, 2010 19-Oct-2010
Boston Scientific Announces Global Launch of Journey(TM) Guidewire 13-Oct-2010
Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 7-Oct-2010
Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy 28-Sep-2010
HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS(R) Drug-Eluting Stent in Heart Attack Patients 25-Sep-2010
Boston Scientific's TAXUS(R) Element(TM) Stent Demonstrates Strong Outcomes in Diabetic Patients 22-Sep-2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions 22-Sep-2010
Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element(TM) Stent 21-Sep-2010
PROMUS(R) Element(TM) Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries 21-Sep-2010
Boston Scientific to Acquire Asthmatx 20-Sep-2010
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds 16-Sep-2010
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium 14-Sep-2010
Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 2-Sep-2010
Boston Scientific to Help Raise Awareness of Heart Disease Risk Factors at the Kirk Herbstreit National Kickoff Classic 26-Aug-2010
Boston Scientific's Women's Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association 19-Aug-2010
Boston Scientific Resolves Corporate Warning Letter 11-Aug-2010
Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating 3-Aug-2010
Boston Scientific Announces FDA Approval of New Leads for the Precision Plus(TM) Spinal Cord Stimulator System 29-Jul-2010
Boston Scientific to Participate in BMO Capital Markets Healthcare Conference 29-Jul-2010
Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe 26-Jul-2010
Boston Scientific Announces Results for Second Quarter Ended June 30, 2010 20-Jul-2010
Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial 8-Jul-2010
Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results 7-Jul-2010
Boston Scientific Announces FDA Approval and Launch of Lead Splitters for the Precision Plus(TM) Spinal Cord Stimulator System 24-Jun-2010
Boston Scientific Announces Completion of Refinancing 2011 Debt Maturities With New $3 Billion Bank Credit Facilities 23-Jun-2010
Boston Scientific Expands PolarCath(R) Peripheral Dilatation System With New Balloon Sizes 21-Jun-2010
MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men 18-Jun-2010
Boston Scientific to Participate in Wells Fargo Healthcare Conference 14-Jun-2010
Boston Scientific Announces Schedule for Cardiostim World Congress 11-Jun-2010
Boston Scientific Announces European Launch and First Implants of Platinum Chromium TAXUS(R) Element(TM) Stent System 10-Jun-2010
Boston Scientific to Participate in Goldman Sachs Healthcare Conference 2-Jun-2010
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System 26-May-2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex(TM) Balloon Catheter 25-May-2010
Boston Scientific Announces Collaborations on Cardiovascular Imaging Technology With Philips and Siemens 24-May-2010
Boston Scientific Announces Schedule for EuroPCR 2010 20-May-2010
Boston Scientific Launches Sterling(R) SL Balloon Catheter in U.S. and Europe 19-May-2010
FDA Approves Boston Scientific's Genesys HTA(TM) System 18-May-2010
Boston Scientific Announces FDA Clearance of New Heart Failure Lead Delivery System 13-May-2010
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System 12-May-2010
Boston Scientific Announces FDA Approval for LATITUDE(R) Patient Management System Software Upgrade 11-May-2010
Boston Scientific Announces Schedule of Key Events for Heart Rhythm Society Scientific Sessions 10-May-2010
Study Shows Endoscopic Duodenal Stenting Is Associated With Lower Costs and Shorter Hospital Stays Compared To Surgery for Relief of Malignant Gastric Outlet Obstruction 4-May-2010
Boston Scientific Begins Groundbreaking Clinical Trial Comparing Spinal Cord Stimulation to Spine Reoperation In Patients With Failed Back Surgery Syndrome 3-May-2010
Boston Scientific's Endoscopy Products Featured in Clinical Studies at DDW 2010 30-Apr-2010
Boston Scientific Launches Pelvic Floor Institute(TM) to Expand Physician Training for Urology and Women's Health Procedures 29-Apr-2010
Boston Scientific Expresses Willingness To Discuss Modification of Guidant Plea Agreement 27-Apr-2010
Boston Scientific Announces Results for First Quarter Ended March 31, 2010 26-Apr-2010
Boston Scientific Announces Launch of Kinetix(TM) Guidewire 22-Apr-2010
Boston Scientific to Participate in Bank of America Merrill Lynch Health Care Conference 21-Apr-2010
Boston Scientific To Participate in Deutsche Bank 35th Annual Health Care Conference 19-Apr-2010
Boston Scientific's Urology and Women's Health Division Strengthens Marketing Alliance With Bladder Health Network 19-Apr-2010
Boston Scientific to Immediately Resume Distribution of COGNIS(R) CRT-Ds and TELIGEN(R) ICDs in the U.S. 15-Apr-2010
Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results 15-Apr-2010
FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Based on Landmark MADIT-CRT Trial 27-Mar-2010
FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Based on Landmark MADIT-CRT Trial 18-Mar-2010
Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions 16-Mar-2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 15-Mar-2010
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS(R) Element(TM) Stent System 15-Mar-2010
Boston Scientific Announces Ship Hold and Inventory Retrieval of ICD and CRT-D Devices 15-Mar-2010
FDA Approves Boston Scientific's Express(R) LD Iliac Stent System 11-Mar-2010
Boston Scientific Announces Schedule for ACC 2010 10-Mar-2010
Boston Scientific to Participate in RBC Capital Markets Health Care Conference 23-Feb-2010
Boston Scientific Rebuts HeartRhythm Article 10-Feb-2010
Boston Scientific Announces Management Changes and Restructuring Initiatives 10-Feb-2010
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2009 10-Feb-2010
Boston Scientific Settles Longstanding Patent Disputes With J&J 1-Feb-2010
Court Finds J&J Patents Invalid 20-Jan-2010
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results 19-Jan-2010
Boston Scientific Announces Enrollment of First Patient in Benign Stricture Study of WallFlex(R) Biliary RX Stent 14-Jan-2010
Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System 8-Jan-2010
Boston Scientific to Participate in J.P. Morgan Health Care Conference 5-Jan-2010
Boston Scientific Announces Completion of Enrollment in Aneurysm Coiling Clinical Trial 5-Jan-2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent 4-Jan-2010
Boston Scientific Announces Settlement of DOJ Investigation Relating to Post-Market Surveys Conducted By Guidant 23-Dec-2009
Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 16-Dec-2009
Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 14-Dec-2009
Boston Scientific Announces Pricing of $2 Billion of Senior Notes 10-Dec-2009
Boston Scientific to Participate in Piper Jaffray Health Care Conference 23-Nov-2009
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 20-Nov-2009
Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 2009 10-Nov-2009
Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 9-Nov-2009
Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 9-Nov-2009
Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6-Nov-2009
Video: Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System 2-Nov-2009
Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 19-Oct-2009
Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 9-Oct-2009
Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents 6-Oct-2009
Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial 5-Oct-2009
Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes 29-Sep-2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years 25-Sep-2009
SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents 23-Sep-2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions 22-Sep-2009
Boston Scientific PROMUS(R) and First-Generation TAXUS(R) Express(R) Stents Continue Excellent Performance in SPIRIT III Trial 21-Sep-2009
Boston Scientific Announces Release of Next-Generation iLab(R) System Software 21-Sep-2009
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 18-Sep-2009
Boston Scientific Announces Schedule of Events at TCT Conference 16-Sep-2009
Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network 14-Sep-2009
Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 10-Sep-2009
Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference 4-Sep-2009
Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery 2-Sep-2009
PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors 1-Sep-2009
Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression 1-Sep-2009
Boston Scientific Names Leading Electrophysiologist to Its Medical Team 31-Aug-2009
Boston Scientific Announces Schedule for European Society of Cardiology Congress 27-Aug-2009
Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial 24-Aug-2009
Boston Scientific to Participate in BMO Capital Markets Health Care Conference 3-Aug-2009
Boston Scientific Announces Election of Katharine Bartlett and Bruce Byrnes to Its Board of Directors 29-Jul-2009
Boston Scientific Announces Results for Second Quarter Ended June 30, 2009 20-Jul-2009
FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent 16-Jul-2009
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 13-Jul-2009
Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results 7-Jul-2009
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO 25-Jun-2009
MADIT-CRT Trial Meets Primary Endpoint 23-Jun-2009
Boston Scientific to Participate in Wachovia Conference 18-Jun-2009
Boston Scientific's Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting 15-Jun-2009
Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R) 28-May-2009
FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System 28-May-2009
Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy 27-May-2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System 27-May-2009
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial 26-May-2009
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease 20-May-2009
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease 20-May-2009
Fitch Raises Boston Scientific's Rating Outlook to Positive 19-May-2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System 19-May-2009
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 19-May-2009
Boston Scientific Welcomes Launch of Syntax Score Website 19-May-2009
Boston Scientific to Participate in Piper Jaffray PCR Post-Op Summit 15-May-2009
Boston Scientific Announces Schedule for EuroPCR 2009 15-May-2009
Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 14-May-2009
New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy 14-May-2009
Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients 13-May-2009
Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process 12-May-2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent 11-May-2009
Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions 11-May-2009
Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 6-May-2009
Boston Scientific to Participate in Bank of America and Merrill Lynch Conference 5-May-2009
Boston Scientific Announces Results For First Quarter Ended March 31, 2009 20-Apr-2009
Boston Scientific Announces First Quarter Special Items 15-Apr-2009
Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results 6-Apr-2009
Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed 31-Mar-2009
Boston Scientific Welcomes House Passage of National Pain Care Policy Act 31-Mar-2009
Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 29-Mar-2009
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 28-Mar-2009
Boston Scientific Announces Schedule For ACC 2009 26-Mar-2009
Standard and Poor's Raises Boston Scientific's Rating Outlook to Positive 25-Mar-2009
Boston Scientific Launches New Coronary Imaging Catheter 19-Mar-2009
Moody's Raises Boston Scientific's Rating Outlook to Stable 12-Mar-2009
Boston Scientific to Participate in Cowen Health Care Conference 10-Mar-2009
Boston Scientific Welcomes Committee Approval of the National Pain Care Policy Act 4-Mar-2009
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System 3-Mar-2009
Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 2-Mar-2009
Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 26-Feb-2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 18-Feb-2009
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5-Feb-2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 3-Feb-2009
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008 28-Jan-2009
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System 28-Jan-2009
Boston Scientific and Medtronic Reach Agreement on Patent Disputes 27-Jan-2009
Boston Scientific Awarded CRM Contract by Department of Veterans Affairs 20-Jan-2009
Boston Scientific Announces Court Decision 15-Jan-2009
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results 13-Jan-2009
Boston Scientific to Participate in JP Morgan Health Care Conference 7-Jan-2009
Boston Scientific Acquires Labcoat Limited 6-Jan-2009
Boston Scientific Initiates Carotid Stent Clinical Study 18-Dec-2008
FDA Approves Boston Scientific's Express(R) SD Renal Stent System 15-Dec-2008
Boston Scientific to Participate in Piper Jaffray Health Care Conference 24-Nov-2008
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter 10-Nov-2008
Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 29-Oct-2008
UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain 27-Oct-2008
FDA Approves Boston Scientific's Carotid Artery Stent 23-Oct-2008
Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 21-Oct-2008
HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients 15-Oct-2008
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated with Second-Generation TAXUS(R) Liberte(R) Stent 15-Oct-2008
SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery 14-Oct-2008
Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet 14-Oct-2008
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 14-Oct-2008
GE Healthcare and Boston Scientific Collaborate on Cardiovascular Imaging 13-Oct-2008
Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders 13-Oct-2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 12-Oct-2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 12-Oct-2008
Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 10-Oct-2008
Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 10-Oct-2008
Boston Scientific Comments on Involuntary Selling of Its Stock by Co-Founders 9-Oct-2008
Boston Scientific Announces Third Quarter Adjustments 8-Oct-2008
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 8-Oct-2008
Boston Scientific Announces Court Decision 1-Oct-2008
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels 25-Sep-2008
Boston Scientific to Participate in UBS Global Life Sciences Conference 19-Sep-2008
Boston Scientific Announces Court Decision 15-Sep-2008
Boston Scientific to Participate in Bank of America Conference 9-Sep-2008
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated With Second-Generation TAXUS(R) Liberte(R) Stent 2-Sep-2008
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 1-Sep-2008
Court Rejects Two Medtronic Patents 29-Aug-2008
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 26-Aug-2008
Boston Scientific Announces Results for Second Quarter Ended June 30, 2008 21-Jul-2008
Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2-Jul-2008
Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results 26-Jun-2008
Boston Scientific Welcomes Progress on Pain Care Legislation 23-Jun-2008
Boston Scientific Announces Agreements to Sell Non-Strategic Investments 19-Jun-2008
Boston Scientific Welcomes Revised Outlook From Fitch Ratings 9-Jun-2008
Boston Scientific to Participate in Goldman Sachs Conference 5-Jun-2008
Boston Scientific Announces CEO Jim Tobin to Extend Tenure 3-Jun-2008
Boston Scientific Receives LEED Certification for Marlborough, MA Campus 29-May-2008
Boston Scientific Completes Acquisition of CryoCor 28-May-2008
Boston Scientific Announces Court Decision 28-May-2008
Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 20-May-2008
Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System 19-May-2008
Boston Scientific Announces FDA Approval of New Heart Failure Lead 16-May-2008
Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) 16-May-2008
Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 15-May-2008
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 13-May-2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program 13-May-2008
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 13-May-2008
Boston Scientific Announces Sponsorship of World Diabetes Day Campaign 13-May-2008
Boston Scientific Announces Dismissal of Johnson & Johnson Patent Lawsuit in Canada 8-May-2008
Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers 8-May-2008
Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers 7-May-2008
WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents 5-May-2008
Boston Scientific to Participate in Deutsche Bank Conference 30-Apr-2008
Boston Scientific to Participate in Morgan Stanley Conference 24-Apr-2008
Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 24-Apr-2008
Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX) 23-Apr-2008
Boston Scientific Announces Results for First Quarter Ended March 31, 2008 21-Apr-2008
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System 17-Apr-2008
Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 16-Apr-2008
Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 15-Apr-2008
Boston Scientific Announces Japanese Approval of Heart Failure Lead 14-Apr-2008
Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results 7-Apr-2008
Boston Scientific Announces Appointment of Timothy Pratt as General Counsel 7-Apr-2008
District Judge Dismisses Shareholder Suit Related to Boston Scientific 2-Apr-2008
TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials 1-Apr-2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels 1-Apr-2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 31-Mar-2008
Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program 31-Mar-2008
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent 29-Mar-2008
TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries 29-Mar-2008
Boston Scientific Announces Schedule for ACC 2008 25-Mar-2008
Boston Scientific to Participate in Lehman Brothers Health Care Conference 11-Mar-2008
Boston Scientific Announces European Approval of New Heart Failure Lead 3-Mar-2008
Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death 28-Feb-2008
Boston Scientific Announces Addition to Clinical Sciences Organization 26-Feb-2008
Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 25-Feb-2008
Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 14-Feb-2008
Boston Scientific Announces Court Decision 12-Feb-2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 11-Feb-2008
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 4-Feb-2008
Boston Scientific Launches Educational Initiative to Address Disparities in Cardiovascular Care 4-Feb-2008
Boston Scientific to Participate in Merrill Lynch Conference 30-Jan-2008
Boston Scientific Comments on New England Journal of Medicine Article 23-Jan-2008
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2007 Financial Results 23-Jan-2008
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 22-Jan-2008
Boston Scientific Announces Court Decision 7-Jan-2008
Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 7-Jan-2008
Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 4-Jan-2008
Boston Scientific to Participate in JP Morgan Health Care Conference 3-Jan-2008
Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator 28-Dec-2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients 21-Dec-2007
Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 13-Dec-2007
Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System 29-Nov-2007
Boston Scientific to Participate in BMO Capital Markets Healthcare Conference 28-Nov-2007
Boston Scientific to Participate in Piper Jaffray Health Care Conference 21-Nov-2007
Boston Scientific Announces Amended Agreement to Settle Product Lawsuits 19-Nov-2007
Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record 6-Nov-2007
Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 5-Nov-2007
Boston Scientific Announces Verdict in Cordis Litigation 31-Oct-2007
Boston Scientific Announces Additions to Clinical Sciences Organization 26-Oct-2007
Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 23-Oct-2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 22-Oct-2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions 22-Oct-2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 22-Oct-2007
ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 21-Oct-2007
Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19-Oct-2007
Boston Scientific Announces New Initiatives to Increase Shareholder Value 17-Oct-2007
Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 16-Oct-2007
Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator 9-Oct-2007
Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 1-Oct-2007
Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System 14-Sep-2007
Boston Scientific Announces Election of Ray Elliott to Its Board of Directors 6-Sep-2007
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women 5-Sep-2007
Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4-Sep-2007
Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 2-Sep-2007
Boston Scientific Announces Agreement to Settle with State Attorneys General 30-Aug-2007
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007 29-Aug-2007
Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference 28-Aug-2007
Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan 23-Aug-2007
Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses 16-Aug-2007
Boston Scientific, Advanced Bionics Principals Announce Strategic Accord 9-Aug-2007
Boston Scientific Provides Strategic Update 2-Aug-2007
Boston Scientific to Explore Sale of Fluid Management Business 24-Jul-2007
Boston Scientific Announces Results for Second Quarter Ended June 30, 2007 20-Jul-2007
Boston Scientific Announces First Implant of TAXUS(R) Element(TM) Platinum Chromium Stent 19-Jul-2007
Boston Scientific Announces First Human Use of TAXUS(R) Petal(TM) Bifurcation Stent 17-Jul-2007
Boston Scientific Announces Agreement to Settle Product Lawsuits 13-Jul-2007
Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results 10-Jul-2007
Boston Scientific Announces Launch of New Precision Plus(TM) Spinal Cord Stimulation System 2-Jul-2007
Boston Scientific and CryoCor Announce Strategic Collaboration in Atrial Fibrillation 28-Jun-2007
Boston Scientific Announces Agreement to Acquire Remon Medical Technologies, Inc. 25-Jun-2007
Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation 21-Jun-2007
Boston Scientific to Participate in Goldman Sachs Conference 8-Jun-2007
Positive Results for Second-Generation Taxus(R) Liberte(TM) Coronary Stent System Highlighted in Journal of American College of Cardiology 4-Jun-2007
First Patient Enrolled in SONOMA Post-Market Approval Study of Boston Scientific NexStent(R) Carotid Stent System and FilterWire EZ(TM) Embolic Protection Device 31-May-2007
Boston Scientific Receives CE Mark for TAXUS(R) Liberte(TM) Long Stent 24-May-2007
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems 22-May-2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents 22-May-2007
TAXUS VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years 22-May-2007
Boston Scientific Joins U.S. Climate Action Partnership 18-May-2007
Boston Scientific Announces Schedule for Digestive Disease Week(R) 2007 18-May-2007
Boston Scientific Announces Worldwide Launch Of Spyglass(TM) Direct Visualization System 17-May-2007
Boston Scientific Announces Schedule for EuroPcr 2007 15-May-2007
World's Largest Drug-Eluting Stent Registry Completes European and Intercontinental Enrollment Phases 14-May-2007
Boston Scientific Comments on Positive Results with the FLEX(TM) Microwave Ablation System 10-May-2007
Boston Scientific Releases Remote Monitoring Data from First 10,000 Patients Using Its Wireless LATITUDE(R) Patient Management System 9-May-2007
Boston Scientific Announces Japanese Launch of TAXUS(R) Express2(TM) Coronary Stent System 8-May-2007
Boston Scientific Announces Two-Year Results From Study of Patients With Renal Artery Disease 3-May-2007
Boston Scientific Announces New CFO 1-May-2007
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery 26-Apr-2007
Boston Scientific To Participate in Morgan Stanley Conference 24-Apr-2007
Boston Scientific Announces Results For First Quarter Ended March 31, 2007 23-Apr-2007
Boston Scientific Announces FDA Approval of Innovative Heart Failure Lead 17-Apr-2007
Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results 16-Apr-2007
Boston Scientific Resolves CRM Warning Letter Deficiencies 16-Apr-2007
Boston Scientific Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System 3-Apr-2007
Boston Scientific Announces Enrollment of First Patient in MAPS(TM) Clinical Trial 2-Apr-2007
CryoPlasty(R) Provides Alternative to Amputation For Patients With Blocked Arteries Below The Knee 26-Mar-2007
Boston Scientific Reports Positive Two-Year Data From TAXUS V ISR Trial 25-Mar-2007
Boston Scientific Announces Results From Arrive 1 Registry Supporting Positive Performance of TAXUS(R) Stent System in Complex Patients 25-Mar-2007
Spirit III Clinical Trial Demonstrates Positive Performance for Both TAXUS(R) and PROMUS(TM) Drug-Eluting Stent Systems 24-Mar-2007
Boston Scientific Announces Industry-Leading Program to Improve Anti-Platelet Compliance for DES Patients 23-Mar-2007
Boston Scientific Announces Japanese Approval of Implantable Defibrillator for the Treatment of Irregular Heart Rhythms 22-Mar-2007
Boston Scientific iLab(TM) System Hits Record Sales 21-Mar-2007
Boston Scientific Announces Schedule for ACC 2007 20-Mar-2007
Boston Scientific to Participate in Lehman Brothers Health Care Conference 13-Mar-2007
Boston Scientific To Explore IPO of Minority Interest in Its Endosurgery Group 12-Mar-2007
Boston Scientific Announces Governance Enhancements 8-Mar-2007
Boston Scientific to Participate in Cowen Health Care Conference 6-Mar-2007
Boston Scientific to Provide Information to House Committee on Oversight and Government Reform 5-Mar-2007
Boston Scientific Announces Launch of Race Against Pain(SM) Campaign to Shine Spotlight on Pain Management Technology 28-Feb-2007
Boston Scientific Comments on Swedish Registry Results 12-Feb-2007
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents 12-Feb-2007
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes 5-Feb-2007
Boston Scientific Comments on CMS Proposal To Expand Coverage of Carotid Artery Stenting 2-Feb-2007
Boston Scientific Announces Results for Year and Fourth Quarter Ended December 31, 2006 1-Feb-2007
Boston Scientific Announces Updated Time for Webcast of Conference Call Discussing Fourth Quarter and 2006 Financial Results 31-Jan-2007
FDA Grants Boston Scientific Clearance to Expand PolarCath(TM) Peripheral Dilatation System Offering with New Balloon Length 29-Jan-2007
Boston Scientific To Webcast Conference Call Discussing Fourth Quarter and 2006 Financial Results 25-Jan-2007
FDA Approves 18-Month Shelf Life for TAXUS(R) Stent System 18-Jan-2007
Boston Scientific and Angiotech Win Patent Infringement Case Against Conor in the Netherlands 17-Jan-2007
Boston Scientific Comments on U.K. Court Decision on Angiotech Patent 16-Jan-2007
Study in European Heart Journal Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients 12-Jan-2007
Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System 11-Jan-2007
Boston Scientific Announces Preliminary Sales for Fourth Quarter and 2006 10-Jan-2007
Boston Scientific Announces Plan To Reallocate CRM Research and Development Resources 8-Jan-2007
Boston Scientific Acquires EndoTex Interventional Systems, Inc. 4-Jan-2007
Boston Scientific to Participate in JP Morgan Health Care Conference 3-Jan-2007
Landmark Defibrillator Study Shows Benefits of Dual-Chamber Pacing 2-Jan-2007
Boston Scientific Announces Nationwide Recall of 51 Mach 1 Guide Catheters 15-Dec-2006
FilterWire EZ(TM) Embolic Protection System Cleared By FDA For Carotid Artery Stenting 14-Dec-2006
Real-World Taxus(R) Stent Data Confirm Favorable Outcomes for Patients With Complex Coronary Artery Disease 7-Dec-2006
Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures 7-Dec-2006
Boston Scientific to Participate in Piper Jaffray Health Care Conference 21-Nov-2006
Boston Scientific to Appoint Brenda Becker Senior Vice President, Global Government Affairs 15-Nov-2006
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients 14-Nov-2006
Boston Scientific and GE Healthcare Announce the First Integration of Remote Device Information Direct to Electronic Medical Records 9-Nov-2006
Boston Scientific Announces Financial Outlook for 2007 6-Nov-2006
TAXUS Long-Term Data Excels in Diabetic Patients 6-Nov-2006
Boston Scientific Announces Japanese Approval of Liberte(TM) Bare-Metal Coronary Stent System 6-Nov-2006
Boston Scientific Announces FDA Approval of NexStent(R) Carotid Artery Stenting System 3-Nov-2006
Boston Scientific Receives CE Mark for Artisan(TM) Surgical Lead for Use With Neurostimulation Device to Treat Chronic Pain 3-Nov-2006
Boston Scientific Appoints Daniel J. Brennan Vice President of Investor Relations 2-Nov-2006
Boston Scientific to Webcast Analyst Meeting 2-Nov-2006
Boston Scientific Announces Availability of Advanced Feature in Company's Heart Failure Devices 1-Nov-2006
Boston Scientific Appoints Steven L. Zelenkofske Patient Safety Officer and Vice President, Clinical Sciences for Cardiac Rhythm Management Group 31-Oct-2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months 25-Oct-2006
Data in Complex Patients and Lesions from OLYMPIA Registry Support Safety and Efficacy of TAXUS(R) Liberte(TM) Stent System 25-Oct-2006
Independent Meta-Analysis Confirms Safety and Efficacy of TAXUS Stent 23-Oct-2006
Boston Scientific Reports Positive Results for its Carotid Artery Stenting Trial 23-Oct-2006
Boston Scientific to Support Landmark STENT Thrombosis Study 23-Oct-2006
TAXUS(R) Performance Superior to Cypher(R) in Diabetic Patients in Head-to-Head Study 22-Oct-2006
Boston Scientific Announces Results for Third Quarter Ended September 30, 2006 18-Oct-2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006 18-Oct-2006
Boston Scientific Launches Clinical Trial to Study Endovascular Treatment of Brain Aneurysms 16-Oct-2006
Boston Scientific Becomes only Company with Two Drug-Eluting Stent Platforms With European Approval of Everolimus-Eluting PROMUS(TM) Stent System 16-Oct-2006
Court Rules in Favor of Guidant Over Medtronic 12-Oct-2006
Boston Scientific to Webcast Conference Call Discussing Third Quarter 2006 Financial Results 4-Oct-2006
Boston Scientific Announces Major Expansion of its LATITUDE(R) Patient Management System 2-Oct-2006
Boston Scientific to Adopt HRS Guidelines 28-Sep-2006
Boston Scientific Announces FDA Approval of Harmony(TM) HiResolution(R) Bionic Ear System 27-Sep-2006
Boston Scientific Announces Excellent Results for Patients With Blocked Arteries Below the Knee 26-Sep-2006
Boston Scientific Announces Preliminary Sales and Earnings for Third Quarter 21-Sep-2006
Boston Scientific Announces Market Launch of the First Less-Invasive, Unilateral Visualization System for Cardiac Surgical Ablation 19-Sep-2006
Boston Scientific Welcomes FDA Statement on Drug-Eluting Stents 14-Sep-2006
Safety and Efficacy of Drug-Eluting Stents Reaffirmed in New England Journal of Medicine Articles and Editorial 13-Sep-2006
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years 6-Sep-2006
OLYMPIA Phase I Registry Demonstrates Safety and Performance of TAXUS(R) Liberte(TM) Stent System in Complex Patients and Lesions 5-Sep-2006
SPIRIT II Results Highlight Strength of Boston Scientific Stent Portfolio 5-Sep-2006
PROMUS(TM) Everolimus-Eluting Stent Added to Boston Scientific Coronary Stent Portfolio 1-Sep-2006
World's Largest Drug-Eluting Stent Registry Reaches Halfway Point in Enrollment 31-Aug-2006
Boston Scientific Expects Results at Upcoming World Congress of Cardiology to Reinforce Safety & Efficacy Record of TAXUS(R) Drug-Eluting Stent Systems 30-Aug-2006
Boston Scientific Announces Results for Second Quarter Ended June 30, 2006 27-Jul-2006
Boston Scientific Announces Treatment of 5,000th Chronic Pain Patient with its Innovative Neuromodulation Technology 26-Jul-2006
OLYMPIA Phase I Registry Demonstrates Efficacy of TAXUS(R) Liberte(TM) Stent System in Complex Patients and Lesions 24-Jul-2006
Boston Scientific's iLab(TM) Ultrasound Imaging System Makes it Easier to View Within the Heart and Vessels 14-Jul-2006
Boston Scientific Launches Radial Jaw(R) 4, Newest Version of Single-Use Biopsy Forceps 12-Jul-2006
Boston Scientific Appoints William E. Young Vice President of Quality Assurance and Reliability for Cardiac Rhythm Management Group 10-Jul-2006
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2006 Financial Results 10-Jul-2006
Boston Scientific Ranked Number One Medical Device Company for Technology Strength in UBS Investment Research Report 28-Jun-2006
Boston Scientific Announces Physician Communication Related to Products in Its CRM Group 26-Jun-2006
Boston Scientific to Participate in Jefferies Life Science Conference 23-Jun-2006
Boston Scientific Announces Court Upholds Jury Verdict Against J&J 15-Jun-2006
Data from Largest Independent U.S. Drug-Eluting Stent Registry Shows Excellent Outcomes for TAXUS(R) Stent System in Diabetics 12-Jun-2006
Boston Scientific to Participate in Goldman Sachs Conference 9-Jun-2006
Boston Scientific Announces Completion of $1.2 Billion Senior Notes Offering 9-Jun-2006
Boston Scientific Announces Pricing of $1.2 Billion of Senior Notes 6-Jun-2006
Boston Scientific Launches New Balloon Catheters Designed to Address Wide Variety of Peripheral Intervention Needs 6-Jun-2006
FDA Clears Boston Scientific System for Removing Clots from Arteries 31-May-2006
Court of Appeals Rules Boston Scientific's Products do Not Infringe Medtronic Stent Patents 26-May-2006
Study Shows That SpyGlass(TM) Direct Visualization System May Alter ERCP Diagnosis and Treatment Strategy 22-May-2006
Boston Scientific announces Results for Large Clinical Trial Studying Dual-Chamber Pacing in Implantable Cardioverter Defibrillators 20-May-2006
Boston Scientific Launches Two Large-Scale Studies of Wireless Home Monitoring System for Heart Failure Patients 19-May-2006
Boston Scientific's Cardiac Rhythm Management Group Announces One-Year Anniversary of Innovative Wireless Device with More than 5,000 Worldwide Implants 18-May-2006
Boston Scientific to Release Broad Range of Clinical Results on Endoscopic Technologies at DDW(R) 2006 18-May-2006
Boston Scientific to Add New European Institute for Therapy Advancement Campus to Global Medical Education Network 17-May-2006
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients 17-May-2006
Moderate-Release TAXUS(R) Express(TM) Coronary Stent System Demonstrates Sustained Long-Term Outcomes in High-Risk Patients 16-May-2006
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System 16-May-2006
MELODIE Clinical Trial Reports Excellent Safety and Efficacy Results for Express(TM) Vascular LD Stent in the Treatment of Blocked Iliac Arteries 16-May-2006
TAXUS(R) Liberte(TM) Stent System Receives European Approval for Three Complex Coronary Procedures 16-May-2006
Boston Scientific Announces Physician Communications Related to Products in Its CRM Group 15-May-2006
Boston Scientific Announces Court Upholds Jury Decisions in Patent Case with J&J 11-May-2006
Boston Scientific Announces Appointment of Donald Baim, M.D., as Chief Medical and Scientific Officer 11-May-2006
Boston Scientific and BioForm Medical Announce FDA Approval of Coaptite(R) Injectable Implant 10-May-2006
Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR 9-May-2006
Boston Scientific Sues Conor Medsystems Ireland Ltd. 4-May-2006
Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands 3-May-2006
Boston Scientific Launches Innovative Technologies for Less-Invasive Coronary Artery Bypass Surgery 1-May-2006
Boston Scientific to Participate in Morgan Stanley Conference 28-Apr-2006
Boston Scientific to Participate in Deutsche Bank Conference 28-Apr-2006
Boston Scientific to Implement All Recommendations of Heart Rhythm Society Report 26-Apr-2006
Boston Scientific Announces Election of Kristina Johnson and Nancy-Ann DeParle to the Board of Directors 26-Apr-2006
Boston Scientific Announces Interest Rate Adjustment to its Senior Notes Due 2015 and 2035 21-Apr-2006
Boston Scientific Announces Results for First Quarter Ended March 31, 2006 18-Apr-2006
Boston Scientific Announces First Patient Implanted in Clinical Trial Assessing Neurostimulation as a Treatment for Migraine 17-Apr-2006
Boston Scientific to Webcast Conference Call Discussing First Quarter 2006 Financial Results 7-Apr-2006
Boston Scientific Receives FDA Clearance for Super Sheath(TM) Introducer Sheath 3-Apr-2006
Boston Scientific and Guidant Shareholders Each Approve Combination 31-Mar-2006
Boston Scientific Launches ZIPwire(TM) Guide Wire for Diagnostic and Interventional Procedures 30-Mar-2006
ACC Data Show Numerical Trend Favoring TAXUS(R) Coronary Stent System 29-Mar-2006
Federal Judge Rules on Motions 27-Mar-2006
Boston Scientific Makes Antitrust Commitments To European Commission 23-Mar-2006
JAMA Article Says TAXUS(R) Stents Superior to Brachytherapy in the Treatment of In-Stent Restenosis 15-Mar-2006
ARRIVE II Registry Demonstrates Low 2.5 Percent TAXUS-Related Re-Intervention Rate in Complex Lesions 14-Mar-2006
STENT Registry Safety Data Favors TAXUS(R) Over Cypher(R) in the Most Complex Diabetic Patients 12-Mar-2006
Excellent In-Stent Restenosis Clinical Trial Results Reported for Taxus Stent System 12-Mar-2006
Boston Scientific Announces Leadership Team for New Cardiac Rhythm Management Group 10-Mar-2006
Boston Scientific Submits Final Module for TAXUS(R) Liberte(TM) Coronary Stent System Application 8-Mar-2006
Boston Scientific to Release Broad Range of Clinical Study Results on Market-Leading Taxus(R) Coronary Stent System at ACC 2006 7-Mar-2006
Boston Scientific to Participate in Lehman Brothers Conference 3-Mar-2006
Boston Scientific to Participate in SG Cowen & Co. 26th Annual Health Care Conference 1-Mar-2006
Boston Scientific Announces French Reimbursement for TAXUS(R) Liberte(TM) Paclitaxel-Eluting Coronary Stent System 15-Feb-2006
Boston Scientific Announces Results for Year and Fourth Quarter Ended December 31, 2005 7-Feb-2006
Statement of Boston Scientific CEO Jim Tobin on FDA Meeting 3-Feb-2006
Boston Scientific to Participate in Merrill Lynch Conference 1-Feb-2006
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2005 Financial Results 31-Jan-2006
Boston Scientific Announces Two Communications From FDA 26-Jan-2006
Boston Scientific Announces Excellent Results in Study of Patients with Renal Artery Disease 23-Jan-2006
Five-Year Study Demonstrates PASV(R) Valve Technology in Boston Scientific's PICC Catheters Significantly Reduced Rates of Both Occlusion and Infection 18-Jan-2006
Boston Scientific Announces Preliminary Sales Results for 2005 and Fourth Quarter 9-Jan-2006
Boston Scientific Announces CEO Jim Tobin to Extend Tenure at Company 5-Jan-2006
Boston Scientific Announces New Medicare Pass-Through Payments for Rechargeable Neurostimulators 4-Jan-2006
Boston Scientific Announces $250,000 Donation to Doctors Without Borders 21-Dec-2005
Boston Scientific Announces $500,000 Fellowship Grant to University of Minnesota Foundation 14-Dec-2005
Boston Scientific Honored with American Red Cross Circle of Humanitarian Award 8-Dec-2005
Boston Scientific Announces Worldwide Recall of Flextome Cutting Balloon(R) Systems 8-Dec-2005
Two Boston Scientific Executives to Participate in First Massachusetts Conference For Women 6-Dec-2005
Boston Scientific Announces Interest Rate Adjustment to Its Senior Notes Due 2015 and 2035 5-Dec-2005
Boston Scientific Announces Worldwide Recall of Stainless Steel Greenfield(R) Vena Cava Filters Manufactured Before March 10, 2004 2-Dec-2005
Boston Scientific to Participate in Merrill Lynch Med Tech Conference 23-Nov-2005
Boston Scientific Announces Completion of $750 Million Senior Notes Offering 17-Nov-2005
Boston Scientific Announces Pricing of $750 Million of Senior Notes 14-Nov-2005
Boston Scientific Announces Start of Clinical Trial Assessing Precision(R) Spinal Cord Stimulator for Treatment of Migraine Headaches 10-Nov-2005
Boston Scientific Announces FDA Approval of Artisan(TM) Surgical Lead For Use With Spinal Cord Stimulation System 9-Nov-2005
Boston Scientific and Angiotech Pharmaceuticals Receive Canadian American Business Council 2005 Achievement Award 8-Nov-2005
Boston Scientific Announces New Medicare Reimbursement Codes for Rechargeable Neurostimulators 1-Nov-2005
Boston Scientific to Participate in CIBC Healthcare Conference 31-Oct-2005
TAXUS(R) Stent Demonstrates Excellent Efficacy and Safety in Independent 'STENT' Registry 25-Oct-2005
Boston Scientific Acquires Endoscopic Stent Technologies from Rusch 24-Oct-2005
OLYMPIA Registry Supports Positive Safety Profile of TAXUS(R) Liberte(TM) Stent System 20-Oct-2005
TAXUS(R) Express2(TM) Stent System Shows Significant Reduction of Restenosis in Diabetic Patients in Clinical Trial 20-Oct-2005
Boston Scientific Recognized as Leader in Development of Rigorous Clinical Trials 19-Oct-2005
TAXUS Clinical Trial Data Demonstrates Outstanding Long-Term Safety and Efficacy Record 18-Oct-2005
Boston Scientific Study Shows Excellent Performance in High-Risk Patients with Carotid Artery Disease 17-Oct-2005
Continued Improvement and Outstanding Safety Seen with Boston Scientific's FilterWire EZ(TM) Embolic Protection System 17-Oct-2005
Boston Scientific Announces Third Quarter Results 14-Oct-2005
Boston Scientific Wins Appeal in Patent Infringement Case Against Johnson & Johnson in the Netherlands 13-Oct-2005
Boston Scientific Announces 'Taxus(R) Stent Assurance Program' 13-Oct-2005
Boston Scientific to Release Long-Term Clinical Trial Results on Market- Leading TAXUS(R) Express2(TM) Coronary Stent System at TCT 2005 10-Oct-2005
Boston Scientific to Webcast Conference Call Discussing Third Quarter 2005 Financial Results 7-Oct-2005
Boston Scientific Announces Total Hurricane Relief Donation of $3.3 Million 4-Oct-2005
Boston Scientific Celebrates Grand Opening of Maple Grove, MN Research and Development Center 3-Oct-2005
Boston Scientific and Medinol Announce Settlement 21-Sep-2005
Boston Scientific Celebrates Grand Opening of Marlborough, MA Office Complex 19-Sep-2005
Boston Scientific Receives FDA Clearance for Flextome(TM) Cutting Balloon(R) Dilatation Device 16-Sep-2005
Boston Scientific Manufacturing Facility Named Best Plant by IndustryWeek Magazine 14-Sep-2005
JAMA Article Says TAXUS(R) Stents Half as Likely to Require Reintervention in Complex Lesions 13-Sep-2005
Boston Scientific Receives European Approval to Market Precision(TM) Spinal Cord Stimulation System for Treatment of Chronic Pain 13-Sep-2005
Boston Scientific Announces European Approval for World's First Next- Generation Drug-Eluting Stent System 8-Sep-2005
Three Boston Scientific Drug-Eluting Stent Trials Meet ESC Treatment Guidelines for Improving Patient Outcomes 8-Sep-2005
Boston Scientific Comments on Third Quarter Performance 7-Sep-2005
Boston Scientific to Participate in the Bear Stearns 18th Annual Healthcare Conference 6-Sep-2005
Boston Scientific to Participate in Thomas Weisel Partners Healthcare Conference 1-Sep-2005
Boston Scientific to Donate $500,000 to Hurricane Relief 1-Sep-2005
Boston Scientific Announces Launch of Chilli II(TM) Cooled Ablation Catheter 31-Aug-2005
American Journal of Cardiology Study Finds TAXUS Has Lower MACE Rate Than Cypher 16-Aug-2005
Boston Scientific Issues Update on Medinol Litigation 12-Aug-2005
Boston Scientific Announces Humanitarian Use Approval for Device to Treat Intracranial Atherosclerotic Disease 9-Aug-2005
14-Month-Old Twins Will Hear for the First Time with Initial Activation of Bilateral Cochlear Implants 2-Aug-2005
Boston Scientific Receives 2005 Best Practices in Logistics Management Gold Award 28-Jul-2005
Boston Scientific Announces Second Quarter Results 19-Jul-2005
Boston Scientific Announces 1,000th Patient Treated with Precision(TM) Spinal Cord Stimulation System for Relief from Chronic Pain 11-Jul-2005
Boston Scientific Announces Launch of Matrix2(TM) 360-Degree Detachable Coils 8-Jul-2005
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2005 Financial Results 7-Jul-2005
Boston Scientific Announces Patent Infringement Verdict Against Johnson & Johnson 1-Jul-2005
Boston Scientific Announces Worldwide Recall of Hemashield(R) VANTAGE(TM) Peripheral Vascular Grafts 27-Jun-2005
Boston Scientific Announces Settlement of Department of Justice Investigation of 1998 Recall 24-Jun-2005
Boston Scientific Announces Jury Verdict in Patent Litigation With Johnson & Johnson 21-Jun-2005
Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System Registry Completes First Enrollment Phase 20-Jun-2005
Boston Scientific Completes Acquisition of Rubicon Medical Corporation 15-Jun-2005
Boston Scientific to Participate in Goldman Sachs Conference 9-Jun-2005
Boston Scientific Wins Patent Infringement Case Against Johnson & Johnson in The Netherlands 9-Jun-2005
Boston Scientific Announces Completion of Tender Offer for Rubicon Medical Corporation 2-Jun-2005
Boston Scientific Appoints Lucia Luce Quinn Executive Vice President of Human Resources 1-Jun-2005
Boston Scientific Announces 400th Patient Enrolled in Study of Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System 26-May-2005
ARRIVE Registry Supports Positive Safety Profile of TAXUS(R) Express2(TM) Stent System in Diabetics and Other Patients 25-May-2005
Boston Scientific Provides Updated Financial Estimates for 2005 25-May-2005
Trial Results Support Safety for Next-Generation TAXUS(R) Liberte(TM) Paclitaxel-Eluting Stent System 25-May-2005
TAXUS V Sub-Population Data Further Support Efficacy of TAXUS(R) Express2(TM) Stent System in Diabetic Patients 25-May-2005
Moderate-Release TAXUS(R) Express2(TM) Coronary Stent System Demonstrates Excellent Durability in High-Risk Patients Out to Two Years 24-May-2005
TAXUS V IVUS Results Support Safety and Efficacy in Most Challenging Lesions and Highest-Risk Patients 24-May-2005
Boston Scientific & Aspect Medical Systems Form Strategic Alliance to Develop Brain Monitoring Technology for Diagnosing and Treating Depression & Alzheimer's Disease 23-May-2005
FDA Approves 12-Month Shelf Life for Taxus(R) Stent System 23-May-2005
Boston Scientific to Release Broad Range of Clinical Trial Results on Market- Leading TAXUS(R) Express2(TM) Coronary Stent System and Next-Generation TAXUS(R) Liberte(TM) System at Paris Course on Revascularization 20-May-2005
Four Clinical Studies Support Safety and Effectiveness of ENTERYX(R) Procedure in Treating GERD Symptoms 18-May-2005
Boston Scientific to Participate in Banc of America Securities Health Care Conference 12-May-2005
Boston Scientific to Participate in Deutsche Bank 30th Annual Health Care Conference 28-Apr-2005
Boston Scientific Announces Excellent Results in Study of Patients With Carotid Artery Disease 27-Apr-2005
Boston Scientific Announces Publication of Six TAXUS IV Articles in Prestigious Journal of American College of Cardiology 20-Apr-2005
Boston Scientific Announces First Quarter Results 19-Apr-2005
Boston Scientific Announces Decision to Acquire CryoVascular Systems 18-Apr-2005
Boston Scientific Announces Acquisition of TriVascular, Inc. 18-Apr-2005
Boston Scientific Announces FDA Approval and Launch of Liberte(TM) Coronary Stent System 14-Apr-2005
Boston Scientific Begins Exclusive International Distribution of NexStent(TM) Carotid Stent 13-Apr-2005
Boston Scientific's Quincy Fulfillment Center Receives Prestigious Customer Service Award 12-Apr-2005
Boston Scientific Announces Start of Enrollment in Groundbreaking Clinical Trial Comparing Drug-Eluting Stents to Cardiac Surgery 12-Apr-2005
Boston Scientific Receives 2004 Cadence Management Award for Excellence in Project Management 8-Apr-2005
Boston Scientific to Webcast Conference Call Discussing First Quarter 2005 Financial Results 7-Apr-2005
Boston Scientific to Participate in SunTrust Robinson Humphrey 34th Annual Institutional Investor Conference 6-Apr-2005
Boston Scientific First to Market with Full Range of Large Vessel Drug-Eluting Stent System Sizes 6-Apr-2005
Boston Scientific's TAXUS(R) Express2(TM) Paclitaxel-Eluting Stent System First Drug-Eluting Stent to Receive FDA Approval Allowing Immediate MRI Exams 5-Apr-2005
Revolutionary Technology Offers New Hope for Treating Chronic Pain 29-Mar-2005
Boston Scientific Announces Jury Verdict in Patent Litigation with Johnson & Johnson 24-Mar-2005
Boston Scientific Receives Two FDA Approvals on Cutting Balloon(TM) Product Line 15-Mar-2005
Boston Scientific Facility Receives 2005 Shingo Prize for Excellence in Manufacturing 11-Mar-2005
Boston Scientific to Participate in SG Cowen & Co. 25th Annual Health Care Conference 10-Mar-2005
Boston Scientific Announces Completion of Enrollment in Post-Approval Clinical Trial for the ENTERYX(R) Procedure 9-Mar-2005
Results of REALITY Trial Reaffirm Safety and Efficacy of TAXUS(R) Express2(TM) Paclitaxel-Eluting Stent System 6-Mar-2005
TAXUS V Demonstrates Excellent Safety and Efficacy Results in Most Challenging Lesions and High-Risk Patients 6-Mar-2005
Boston Scientific Announces Completion of Acquisition of Advanced Stent Technologies, Inc. 4-Mar-2005
Boston Scientific to Announce Results from its TAXUS V Drug-Eluting Stent Clinical Trial, Studying Most Challenging Lesions and Highest-Risk Patients 3-Mar-2005
Boston Scientific Announces Start of Enrollment in World's Largest Drug-Eluting Stent Registry 23-Feb-2005
Boston Scientific Announces Completion of Enrollment in Pivotal Clinical Trial For Next-Generation Paclitaxel-Eluting Coronary Stent System 22-Feb-2005
Coil Embolization Treatment 'Safe and Effective,' According to British Health Authority Advisory Committee 16-Feb-2005
Boston Scientific to Participate in Merrill Lynch Conference 2-Feb-2005
Boston Scientific Announces Financial Outlook for 2005, 2006 and 2007 1-Feb-2005
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2004 1-Feb-2005
Physician Feedback Is Extremely Positive as Boston Scientific Completes Initial Launch of TAXUS(R) Liberte(TM) Paclitaxel-Eluting Stent System 31-Jan-2005
Boston Scientific to Webcast Analyst Meeting 27-Jan-2005
Boston Scientific to Participate in Piper Jaffray Health Care Conference 20-Jan-2005
Boston Scientific Announces Implantation of Millionth TAXUS(R) Express2(TM) Coronary Stent System 19-Jan-2005
Boston Scientific Is First to Market With Next-Generation Drug-Eluting Stent System 17-Jan-2005
Boston Scientific Announces Preliminary Sales Results for Fourth Quarter and 2004 10-Jan-2005
U.S. Court Grants Judgment for Boston Scientific in Cases Brought by Medtronic 6-Jan-2005
Boston Scientific to Participate in JPMorgan Healthcare Conference 4-Jan-2005
Boston Scientific to Donate $100,000 to Tsunami Relief 30-Dec-2004
Boston Scientific Announces Management Expansion 20-Dec-2004
Boston Scientific Announces Medicare Reimbursement Codes for Intravascular Ultrasound (IVUS) Procedures 29-Nov-2004
Boston Scientific to Participate in Lazard Freres First Annual Life Sciences Conference 24-Nov-2004
Boston Scientific Exercises Right to Obtain Exclusive Paclitaxel License From Angiotech 23-Nov-2004
French Government Expands Reimbursement For TAXUS(TM) Express 2(TM) Paclitaxel-Eluting Stent System 22-Nov-2004
Boston Scientific Announces Completion of Public Offering of $500 Million Aggregate Principal Amount of Senior Notes 18-Nov-2004
Boston Scientific Announces Strategic Alliance with REVA Medical, Inc. 16-Nov-2004
Boston Scientific Announces Public Offering of Senior Notes 15-Nov-2004
Boston Scientific to Participate in Credit Suisse First Boston Healthcare Conference 12-Nov-2004
Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant 8-Nov-2004
Boston Scientific Highlights TAXUS Data at American Heart Association Meeting 5-Nov-2004
Boston Scientific to Participate in CIBC Conference 4-Nov-2004
Boston Scientific Announces Interim Treatment Satisfaction Data from Three- Year Follow-Up Study 2-Nov-2004
Boston Scientific Announces Three-Month Efficacy Data From Randomized Controlled Trial for Enteryx(R) Procedure 2-Nov-2004
Boston Scientific Announces Two-Year Follow-Up Data from Enteryx(R) Procedure Clinical Trial 2-Nov-2004
Uterine Fibroid Treatment Option 'Safe and Effective,' According to British Health Authority Advisory Committee 1-Nov-2004
Boston Scientific Announces Launch of Broad Line of Mid-Urethral Sling Products 28-Oct-2004
Boston Scientific Announces Start of Enrollment in ARRIVE 2 Drug-Eluting Stent Registry 27-Oct-2004
Boston Scientific Announces Share Repurchase Authorization 26-Oct-2004
Boston Scientific Announces Third Quarter Results 19-Oct-2004
Boston Scientific Announces FDA Clearance For New IQ(TM) Guide Wire 13-Oct-2004
Boston Scientific to Webcast Conference Call Discussing Third Quarter 2004 Financial Results 6-Oct-2004
Boston Scientific Announces 30-Day Safety Data From Its TAXUS V Drug-Eluting Stent Clinical Trial 1-Oct-2004
Boston Scientific Announces Results From TAXUS Registries 1-Oct-2004
Boston Scientific Announces Two-Year Follow-Up Data from TAXUS IV Clinical Trial 29-Sep-2004
Boston Scientific Announces Two-Year Follow-Up Data from TAXUS II Clinical Trial 29-Sep-2004
Boston Scientific Announces Enhancements to U.S. Employee Retirement Plan 28-Sep-2004
Boston Scientific Announces Recall of Advanced Bionics Cochlear Auditory Implants Worldwide 24-Sep-2004
Boston Scientific Announces Schedule of Events at TCT Conference 22-Sep-2004
FDA Completes Galway Inspection; No Observations Reported 8-Sep-2004
Boston Scientific Provides Update on TAXUS Sales and Financial Estimates for Second Half of 2004 1-Sep-2004
Milestone II Registry Reaffirms Positive Safety Outcomes of TAXUS(TM) Express2(TM) Stent System 31-Aug-2004
Boston Scientific Announces Enrollment of First Patient in Clinical Trial for Next-Generation Paclitaxel-Eluting Coronary Stent System 26-Aug-2004
Boston Scientific to Webcast Conference Call Providing 2004 and TAXUS Updates 25-Aug-2004
Boston Scientific Announces FDA Clearance for Peripheral Cutting Balloon(TM) Microsurgical Dilatation Device 25-Aug-2004
Boston Scientific Announces FDA Clearance for FilterWire EZ(TM) Embolic Protection System 23-Aug-2004
FDA Approves Extension of Expiration Date for TAXUS(TM) Express2(TM) Paclitaxel-Eluting Stent System to Nine Months 19-Aug-2004
Boston Scientific Announces Investment in Northstar Neuroscience, Inc. 10-Aug-2004
Boston Scientific Expands Recall of TAXUS Coronary Stent System 5-Aug-2004
Boston Scientific Announces Second Quarter Results 26-Jul-2004
Boston Scientific Receives FDA Approval for Clinical Trial of its Liberte(TM) Paclitaxel-Eluting Coronary Stent System 22-Jul-2004
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2004 Financial Results 21-Jul-2004
Boston Scientific to Recall Additional Coronary Stent Systems 16-Jul-2004
Boston Scientific Announces Enrollment of First Patient in FLAME Clinical Trial 8-Jul-2004
Boston Scientific Recalls 200 TAXUS(TM) Stent Systems 2-Jul-2004
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2004 Financial Results 30-Jun-2004
Boston Scientific Announces Completion of Public Offering of $600 Million Aggregate Principal Amount of 5.45 Percent Senior Notes 25-Jun-2004
Boston Scientific Announces $1 Million Gift to Doctors Without Borders 22-Jun-2004
Boston Scientific Announces Public Offering of Senior Notes 22-Jun-2004
Boston Scientific to Participate in Goldman Sachs Conference 8-Jun-2004
Boston Scientific Announces Preliminary Information on TAXUS Sales For May 3-Jun-2004
Boston Scientific Announces Acquisition of Advanced Bionics Corporation 1-Jun-2004
Boston Scientific Announces Court Decision Upholding Denial of Preliminary Injunction Against TAXUS Drug-Eluting Stent 28-May-2004
Boston Scientific Announces Sub-Population Data from its TAXUS VI Drug-Eluting Stent Trial 26-May-2004
Boston Scientific Announces Positive Results From its TAXUS VI Drug-Eluting Stent Trial 25-May-2004
Boston Scientific Announces Completion of Enrollment in TAXUS(TM) Registry 24-May-2004
Boston Scientific to Webcast Analyst Meeting 20-May-2004
Boston Scientific Announces Sub-Population Data From Enteryx(R) Study 20-May-2004
Boston Scientific Announces 24-Month Safety and Efficacy Data for Enteryx(R) Procedure 18-May-2004
Boston Scientific Announces Preliminary Information on U.S. TAXUS Sales for May 1 - 14 18-May-2004
Boston Scientific to Participate in Banc of America Conference 17-May-2004
Alternatives to Hysterectomies: Women Are Urged to Know Their Options When It Comes to Treating Certain Conditions 10-May-2004
Boston Scientific Announces Preliminary Information on U.S. TAXUS Sales for April 4-May-2004
Boston Scientific to Participate in Morgan Stanley Conference 30-Apr-2004
Boston Scientific Announces 30-Day Safety Data for High-Risk Patient Carotid Stenting Trial 22-Apr-2004
Boston Scientific Announces First Quarter Results 20-Apr-2004
Boston Scientific Announces FDA Clearance for Express(R) Biliary SD Monorail(R) Premounted Stent System 19-Apr-2004
Boston Scientific to Webcast Conference Call Discussing First Quarter 2004 Financial Results 14-Apr-2004
Boston Scientific Launches Sentinol(TM) Self-Expanding Nitinol Biliary Stent System 8-Apr-2004
Boston Scientific Announces Acquisition of Precision Vascular Systems, Inc. 7-Apr-2004
Boston Scientific Announces Preliminary Results Related to First Quarter Sales of Coronary Stent Systems 5-Apr-2004
European Patent Office Declares Medinol Patent Invalid 1-Apr-2004
Boston Scientific Announces Conclusion of Enrollment in TAXUS V Clinical Trial 31-Mar-2004
Boston Scientific Announces FDA Clearance for Contour SE(TM) Embolic Agent for the Treatment of Uterine Fibroids 29-Mar-2004
Boston Scientific and EndoTex Interventional Systems, Inc. Announce Completion Of Enrollment In Carotid Stenting Trial 25-Mar-2004
Boston Scientific Announces Preliminary Information Related to Sales of TAXUS Stent System 22-Mar-2004
Boston Scientific Announces FDA Approval for its TAXUS(TM) Express2(TM) Paclitaxel-Eluting Coronary Stent System 4-Mar-2004
Boston Scientific Acquires Land in Netherlands for New Distribution Center 4-Mar-2004
Boston Scientific to Participate in Lehman Conference 26-Feb-2004
Boston Scientific Addresses Growth Prospects for 2004, 2005 and 2006 23-Feb-2004
Boston Scientific Announces Settlement of All Litigation with Guidant 20-Feb-2004
Boston Scientific Announces Investment in and Strategic Alliance with Cameron Health 20-Feb-2004
Boston Scientific Receives Canadian License for its Carotid Wallstent(R) System 19-Feb-2004
Boston Scientific Announces Strategic Alliance and Investment in Endoscopic Technologies Inc. 18-Feb-2004
Boston Scientific to Webcast Analyst Meeting 17-Feb-2004
Boston Scientific Announces Expansion Plans in Minnesota 17-Feb-2004
Boston Scientific Acquires Office Complex in Marlborough, MA 9-Feb-2004
Boston Scientific Announces Completion of FDA Inspection of Minnesota Drug-Eluting Stent Manufacturing Facility 6-Feb-2004
Boston Scientific Announces Start of Enrollment in U.S.-Based Drug-Eluting Stent Registry 4-Feb-2004
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2003 2-Feb-2004
Court Sets Schedule for Drug-Eluting Stent Litigation Between Boston Scientific and Johnson & Johnson 30-Jan-2004
Boston Scientific Announces French Reimbursement for Taxus(TM) Express2(TM)Paclitaxel-Eluting Stent System 29-Jan-2004
Boston Scientific to Participate in Merrill Lynch Conference 28-Jan-2004
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter 2003 Financial Results 22-Jan-2004
Boston Scientific to Participate in Piper Jaffray Health Care Conference 21-Jan-2004
Boston Scientific Completes Enrollment Of Carotid Stenting Clinical Trial 16-Jan-2004
Boston Scientific Announces Preliminary Results for Fourth Quarter and Year Ended December 31, 2003 13-Jan-2004
Boston Scientific to Participate in JPMorgan Healthcare Conference 6-Jan-2004
Boston Scientific Announces CE Mark for Liberte(TM) Coronary Stent 30-Dec-2003
Boston Scientific Announces Decision of Dutch Court 17-Dec-2003
Boston Scientific Announces Japanese Approval of Express(2TM) Coronary Stent System 10-Dec-2003
Boston Scientific Announces Appointment of Thomas Grissom to Position of Vice President, Government Affairs 9-Dec-2003
Boston Scientific to Participate in Harris Nesbitt Gerard Conference 5-Dec-2003
Boston Scientific Issues Copy of Court Decision on Drug-Eluting Stents 22-Nov-2003
Boston Scientific Announces Court Decision Denying Preliminary Injunctions On Drug Eluting Stents 21-Nov-2003
FDA Panel Recommends Approval for Boston Scientific's TAXUS(TM) Express2(TM) Paclitaxel-Eluting Coronary Stent System 20-Nov-2003
Boston Scientific Announces Medicare Reimbursement Code for Enteryx(R) Procedure 18-Nov-2003
Boston Scientific Announces 12-Month Follow-Up Data From TAXUS IV Clinical Trial 10-Nov-2003
Boston Scientific to Participate in CIBC Conference 3-Nov-2003
British Health Authority Recommends Use of Drug-Eluting Stents 22-Oct-2003
Boston Scientific Announces Third Quarter Results 21-Oct-2003
Boston Scientific to Webcast Conference Call Discussing Third Quarter 2003 Financial Results 14-Oct-2003
Boston Scientific and Carbon Medical Technologies Announce FDA Approval of Durasphere(R) EXP For Treatment of Stress Urinary Incontinence 9-Oct-2003
Boston Scientific Stockholders Approve Charter Amendment 6-Oct-2003
Boston Scientific Manufacturing Facility Named Best Plant By Industry Week Magazine 25-Sep-2003
Boston Scientific to Participate in UBS Conference 22-Sep-2003
Boston Scientific Receives Date for FDA Panel Review of its TAXUS Drug-Eluting Stent System Pre-Market Application 16-Sep-2003
Boston Scientific Announces Positive Results From its Pivotal TAXUS IV Drug-Eluting Stent Trial 15-Sep-2003
Boston Scientific Expects Third Quarter Sales and Earnings to Exceed Prior Guidance 15-Sep-2003
Boston Scientific Announces TCT Schedule for Monday, September 15 15-Sep-2003
Boston Scientific Receives Canadian Approval for its TAXUS Drug-Eluting Stent System 11-Sep-2003
Boston Scientific Announces Strategic Alliance with CryoVascular Systems 10-Sep-2003
Results Of Boston Scientific's TAXUS IV Drug-Eluting Stent Clinical Trial to Be Presented at the TCT Conference On Monday, September 15 10-Sep-2003
Boston Scientific to Webcast Analyst Meeting and Physician Panel Discussion 4-Sep-2003
Boston Scientific Announces FDA Approval of the EPT-1000 XP(TM) Cardiac Ablation System for the Treatment of Atrial Flutter 27-Aug-2003
Boston Scientific Launches Next Generation Intravascular Ultrasound Imaging System 14-Aug-2003
Boston Scientific Announces FDA Clearance for Guglielmi Detachable Coils (GDC(R)) for Expanded Treatment of Brain Aneurysms 12-Aug-2003
Boston Scientific and Corautus Genetics Enter Alliance to Develop and Commercialize Gene Therapy Technology to Treat Cardiovascular Disease 30-Jul-2003
Boston Scientific Announces Stock Split 29-Jul-2003
Boston Scientific Announces Second Quarter Results 22-Jul-2003
Boston Scientific to Webcast Conference Call Discussing Second Quarter 2003 Financial Results 9-Jul-2003
Boston Scientific Provides Mid-Year Update 3-Jul-2003
Boston Scientific to Host Conference Call Providing Mid-Year Update 27-Jun-2003
Boston Scientific Announces Decision in German Patent Litigation 24-Jun-2003
Court of Appeals Upholds Decision in Favor of Boston Scientific On Paclitaxel-Coated Stents 19-Jun-2003
Boston Scientific Submits Fifth and Final Module of PMA For Its TAXUS(TM) Express2(TM) Paclitaxel-Eluting Stent System 19-Jun-2003
Mobile Training Unit Demonstrates New Boston Scientific Embolic Protection System; Provides Physicians with Cutting-Edge Medical Training Opportunity 12-Jun-2003
Boston Scientific Announces Intention to File Fifth and Final Module of PMA for its TAXUS(TM) Express2(TM) Paclitaxel-Eluting Stent System 11-Jun-2003
Boston Scientific Announces Market Approvals for Cutting Balloon Ultra2(TM) Dilatation Device 10-Jun-2003
Boston Scientific Announces FDA Approval For FilterWire EX(TM) Embolic Protection System 9-Jun-2003
Boston Scientific to Participate in Goldman Sachs Conference 6-Jun-2003
Boston Scientific Announces Launch of Blazer RPM(TM) Navigation and Ablation Catheter 28-May-2003
Boston Scientific Announces Additional Follow-Up Data From TAXUS II Clinical Trial 23-May-2003
Boston Scientific Announces Results of Worldwide Multi-Center Enteryx Trial 21-May-2003
Boston Scientific Announces Follow-Up Data From TAXUS Clinical Trials 21-May-2003
Private Practice Gastroenterologists Find Enteryx(R) Procedure Safe and Effective 20-May-2003
Boston Scientific Enters Into Definitive Agreement With EndoTex(TM) Interventional Systems, Inc. 19-May-2003
Boston Scientific Signs Agreement for Advanced Imaging and Navigation Technology 16-May-2003
Body1 and Boston Scientific Launch Online Consumer Resource for Gastric Reflux Sufferers 15-May-2003
Boston Scientific Announces Appointment of Parashar Patel to Position of Vice President, Reimbursement and Outcomes Planning 14-May-2003
Boston Scientific to Webcast Analyst Meeting 9-May-2003
Boston Scientific Announces Governance Actions 6-May-2003
Boston Scientific to Participate in Deutsche Bank Conference 1-May-2003
Boston Scientific Announces FDA Approval For Enteryx(R) Technology 22-Apr-2003
Boston Scientific Announces First Quarter Results 21-Apr-2003
Boston Scientific to Webcast Conference Call Discussing First Quarter 2003 Financial Results 8-Apr-2003
Boston Scientific Announces Settlement of Patent Disputes with Rita Medical Systems, Reports U.S. Attorney 7-Apr-2003
Boston Scientific Announces 12-Month Follow-Up Data From TAXUS II Clinical Trial 30-Mar-2003
Boston Scientific to Announce 12-Month Follow-Up Data From TAXUS II Clinical Trial 27-Mar-2003
Boston Scientific Announces Start of TAXUS V Clinical Trial 18-Mar-2003
Boston Scientific to Participate in SG Cowen Conference 17-Mar-2003
Boston Scientific Announces TAXUS(TM) Paclitaxel-Eluting Coronary Stent System Granted 'Expedited Review' Status By FDA 13-Mar-2003
Boston Scientific and Osiris Therapeutics Announce Stem Cell Alliance 11-Mar-2003
Boston Scientific Announces Submission of First Module of PMA Application For Its TAXUS(TM) Paclitaxel-Eluting Coronary Stent System 25-Feb-2003
Boston Scientific Announces European Launch of its TAXUS(TM) Paclitaxel-Eluting Stent System 18-Feb-2003
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2002 4-Feb-2003
Boston Scientific to Participate in Merrill Lynch Conference 28-Jan-2003
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter 2002 Financial Results 28-Jan-2003
Boston Scientific to Participate in U.S. Bancorp Piper Jaffray Health Care Conference 24-Jan-2003
Boston Scientific Addresses 2003 and 2004 Market Opportunities 21-Jan-2003
Boston Scientific Announces CE Mark For its TAXUS(TM) Paclitaxel-Eluting Stent System 21-Jan-2003
Boston Scientific Announces Preliminary Results for Fourth Quarter and Year Ended December 31, 2002 21-Jan-2003
Boston Scientific and Celsion Corporation Announce Strategic Alliance; Boston Scientific Gains Distribution Rights to Less-Invasive BPH Technology 21-Jan-2003
Boston Scientific Announces FDA Panel Approval of Enteryx(TM) Gastroesophageal Reflux Disease Product 20-Jan-2003
Boston Scientific Completes Enrollment of TAXUS VI Clinical Trial 16-Jan-2003
Boston Scientific to Webcast Analyst Meeting 15-Jan-2003
Boston Scientific Announces Suit By Johnson & Johnson 14-Jan-2003
Boston Scientific and TriVascular, Inc. Announce Strategic Alliance 14-Jan-2003
Boston Scientific Announces Appointment of Charles Carignan, M.D., to Position of Medical Director and Vice President of Clinical Affairs, Endosurgery 7-Jan-2003
Boston Scientific to Participate in JP Morgan H&Q Healthcare Conference 2-Jan-2003
Boston Scientific Announces Second Quarter Results 18-Jul-2001
  Guidant
TITLE DATE
Boston Scientific Completes Combination with Guidant 21-Apr-2006
Boston Scientific Receives FTC Antitrust Approval for its Combination with Guidant 20-Apr-2006
Boston Scientific Receives European Commission's Antitrust Clearance for Guidant Transaction 11-Apr-2006
Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant Transaction 5-Apr-2006
Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve Combination 20-Mar-2006
Boston Scientific and Guidant Proposed Merger Registration Statement Declared Effective 2-Mar-2006
Boston Scientific Files Notification with European Commission 23-Feb-2006
Boston Scientific Files Hart-Scott-Rodino Pre-Merger Notification 6-Feb-2006
Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion 25-Jan-2006
Boston Scientific Acknowledges Guidant Board's Decision 17-Jan-2006
Boston Scientific Announces Offer to Acquire Guidant at $80 Per Share 17-Jan-2006
Boston Scientific Agrees to Two-Hour Extension 13-Jan-2006
Boston Scientific Improves Offer to Acquire Guidant 12-Jan-2006
Boston Scientific Comments on Johnson & Johnson's Amended Agreement to Acquire Guidant 11-Jan-2006
Boston Scientific Announces Agreement to Sell Guidant's Vascular Intervention and Endovascular Businesses to Abbott 8-Jan-2006
Boston Scientific Submits Definitive Offer to Acquire Guidant for $72 Per Share in Cash and Stock 8-Jan-2006
Boston Scientific Comments on Guidant's Announcement 7-Dec-2005
Boston Scientific Proposes to Acquire Guidant for $72 Per Share in Cash and Stock; Transaction Valued at $25 Billion 5-Dec-2005